Back to Newsroom

Symic​ ​Bio​ ​to​ ​Present​ ​at​ ​the​ ​Ladenburg​ ​Thalmann​ ​2017​ ​Annual​ ​Healthcare Conference

SAN​ ​FRANCISCO,​ ​Sept.​ ​18,​ ​2017​ – Symic Bio, a biopharmaceutical company developing novel matrix regulators, today announced that Ken Horne, Chief Executive Officer, will present an overview of the company pipeline at the Ladenburg Thalmann 2017 Healthcare Conference in New York.
READ MORE…